How Analysts Feel About TEARLAB CORP (OTCMKTS:TEAR) After Increase in Sellers?

July 14, 2018 - By Robert Crowder

TearLab Corporation (OTCMKTS:TEAR) Logo

The stock of TEARLAB CORP (OTCMKTS:TEAR) registered an increase of 26.67% in short interest. TEAR’s total short interest was 5,700 shares in July as published by FINRA. Its up 26.67% from 4,500 shares, reported previously. With 40,700 shares average volume, it will take short sellers 0 days to cover their TEAR’s short positions. The short interest to TEARLAB CORP’s float is 0.11%.

The stock decreased 0.45% or $0.001 during the last trading session, reaching $0.166. About 20,871 shares traded. TearLab Corporation (OTCMKTS:TEAR) has 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

TearLab Corporation operates as an in-vitro diagnostic firm in the United States. The company has market cap of $1.73 million. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. It currently has negative earnings. The company??s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.